Global HER2 Antibody Market Growth (Status and Outlook) 2024-2030

December 2024 | 85 pages | ID: G2C97AD0B73BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global HER2 Antibody market size was valued at US$ 13680 million in 2023. With growing demand in downstream market, the HER2 Antibody is forecast to a readjusted size of US$ 22740 million by 2030 with a CAGR of 7.5% during review period.

The research report highlights the growth potential of the global HER2 Antibody market. HER2 Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HER2 Antibody. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HER2 Antibody market.

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.

Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.

Key Features:

The report on HER2 Antibody market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the HER2 Antibody market. It may include historical data, market segmentation by Type (e.g., Trastuzumab, Lapatinib), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HER2 Antibody market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the HER2 Antibody market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the HER2 Antibody industry. This include advancements in HER2 Antibody technology, HER2 Antibody new entrants, HER2 Antibody new investment, and other innovations that are shaping the future of HER2 Antibody.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HER2 Antibody market. It includes factors influencing customer ' purchasing decisions, preferences for HER2 Antibody product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HER2 Antibody market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HER2 Antibody market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HER2 Antibody market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HER2 Antibody industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HER2 Antibody market.

Market Segmentation:

HER2 Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Trastuzumab
• Lapatinib
• Ado-trastuzumab Emtansine
• Pertuzumab
• Everolimus

Segmentation by application

• Hospital
• Medical Center

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Genentech Inc
• Novartis AG
• Pfizer
• Abnova Corporation
• InvivoGen
• Celltrion
• Biocon Limited
• Bio-Techne

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HER2 Antibody Market Size 2019-2030
  2.1.2 HER2 Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 HER2 Antibody Segment by Type
  2.2.1 Trastuzumab
  2.2.2 Lapatinib
  2.2.3 Ado-trastuzumab Emtansine
  2.2.4 Pertuzumab
  2.2.5 Everolimus
2.3 HER2 Antibody Market Size by Type
  2.3.1 HER2 Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global HER2 Antibody Market Size Market Share by Type (2019-2024)
2.4 HER2 Antibody Segment by Application
  2.4.1 Hospital
  2.4.2 Medical Center
2.5 HER2 Antibody Market Size by Application
  2.5.1 HER2 Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global HER2 Antibody Market Size Market Share by Application (2019-2024)

3 HER2 ANTIBODY MARKET SIZE BY PLAYER

3.1 HER2 Antibody Market Size Market Share by Players
  3.1.1 Global HER2 Antibody Revenue by Players (2019-2024)
  3.1.2 Global HER2 Antibody Revenue Market Share by Players (2019-2024)
3.2 Global HER2 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HER2 ANTIBODY BY REGIONS

4.1 HER2 Antibody Market Size by Regions (2019-2024)
4.2 Americas HER2 Antibody Market Size Growth (2019-2024)
4.3 APAC HER2 Antibody Market Size Growth (2019-2024)
4.4 Europe HER2 Antibody Market Size Growth (2019-2024)
4.5 Middle East & Africa HER2 Antibody Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas HER2 Antibody Market Size by Country (2019-2024)
5.2 Americas HER2 Antibody Market Size by Type (2019-2024)
5.3 Americas HER2 Antibody Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HER2 Antibody Market Size by Region (2019-2024)
6.2 APAC HER2 Antibody Market Size by Type (2019-2024)
6.3 APAC HER2 Antibody Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HER2 Antibody by Country (2019-2024)
7.2 Europe HER2 Antibody Market Size by Type (2019-2024)
7.3 Europe HER2 Antibody Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HER2 Antibody by Region (2019-2024)
8.2 Middle East & Africa HER2 Antibody Market Size by Type (2019-2024)
8.3 Middle East & Africa HER2 Antibody Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HER2 ANTIBODY MARKET FORECAST

10.1 Global HER2 Antibody Forecast by Regions (2025-2030)
  10.1.1 Global HER2 Antibody Forecast by Regions (2025-2030)
  10.1.2 Americas HER2 Antibody Forecast
  10.1.3 APAC HER2 Antibody Forecast
  10.1.4 Europe HER2 Antibody Forecast
  10.1.5 Middle East & Africa HER2 Antibody Forecast
10.2 Americas HER2 Antibody Forecast by Country (2025-2030)
  10.2.1 United States HER2 Antibody Market Forecast
  10.2.2 Canada HER2 Antibody Market Forecast
  10.2.3 Mexico HER2 Antibody Market Forecast
  10.2.4 Brazil HER2 Antibody Market Forecast
10.3 APAC HER2 Antibody Forecast by Region (2025-2030)
  10.3.1 China HER2 Antibody Market Forecast
  10.3.2 Japan HER2 Antibody Market Forecast
  10.3.3 Korea HER2 Antibody Market Forecast
  10.3.4 Southeast Asia HER2 Antibody Market Forecast
  10.3.5 India HER2 Antibody Market Forecast
  10.3.6 Australia HER2 Antibody Market Forecast
10.4 Europe HER2 Antibody Forecast by Country (2025-2030)
  10.4.1 Germany HER2 Antibody Market Forecast
  10.4.2 France HER2 Antibody Market Forecast
  10.4.3 UK HER2 Antibody Market Forecast
  10.4.4 Italy HER2 Antibody Market Forecast
  10.4.5 Russia HER2 Antibody Market Forecast
10.5 Middle East & Africa HER2 Antibody Forecast by Region (2025-2030)
  10.5.1 Egypt HER2 Antibody Market Forecast
  10.5.2 South Africa HER2 Antibody Market Forecast
  10.5.3 Israel HER2 Antibody Market Forecast
  10.5.4 Turkey HER2 Antibody Market Forecast
  10.5.5 GCC Countries HER2 Antibody Market Forecast
10.6 Global HER2 Antibody Forecast by Type (2025-2030)
10.7 Global HER2 Antibody Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Genentech Inc
  11.1.1 Genentech Inc Company Information
  11.1.2 Genentech Inc HER2 Antibody Product Offered
  11.1.3 Genentech Inc HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Genentech Inc Main Business Overview
  11.1.5 Genentech Inc Latest Developments
11.2 Novartis AG
  11.2.1 Novartis AG Company Information
  11.2.2 Novartis AG HER2 Antibody Product Offered
  11.2.3 Novartis AG HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Novartis AG Main Business Overview
  11.2.5 Novartis AG Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer HER2 Antibody Product Offered
  11.3.3 Pfizer HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Abnova Corporation
  11.4.1 Abnova Corporation Company Information
  11.4.2 Abnova Corporation HER2 Antibody Product Offered
  11.4.3 Abnova Corporation HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Abnova Corporation Main Business Overview
  11.4.5 Abnova Corporation Latest Developments
11.5 InvivoGen
  11.5.1 InvivoGen Company Information
  11.5.2 InvivoGen HER2 Antibody Product Offered
  11.5.3 InvivoGen HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 InvivoGen Main Business Overview
  11.5.5 InvivoGen Latest Developments
11.6 Celltrion
  11.6.1 Celltrion Company Information
  11.6.2 Celltrion HER2 Antibody Product Offered
  11.6.3 Celltrion HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Celltrion Main Business Overview
  11.6.5 Celltrion Latest Developments
11.7 Biocon Limited
  11.7.1 Biocon Limited Company Information
  11.7.2 Biocon Limited HER2 Antibody Product Offered
  11.7.3 Biocon Limited HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Biocon Limited Main Business Overview
  11.7.5 Biocon Limited Latest Developments
11.8 Bio-Techne
  11.8.1 Bio-Techne Company Information
  11.8.2 Bio-Techne HER2 Antibody Product Offered
  11.8.3 Bio-Techne HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Bio-Techne Main Business Overview
  11.8.5 Bio-Techne Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES
.
Table 1. HER2 Antibody Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Trastuzumab
Table 3. Major Players of Lapatinib
Table 4. Major Players of Ado-trastuzumab Emtansine
Table 5. Major Players of Pertuzumab
Table 6. Major Players of Everolimus
Table 7. HER2 Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global HER2 Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global HER2 Antibody Market Size Market Share by Type (2019-2024)
Table 10. HER2 Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global HER2 Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global HER2 Antibody Market Size Market Share by Application (2019-2024)
Table 13. Global HER2 Antibody Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global HER2 Antibody Revenue Market Share by Player (2019-2024)
Table 15. HER2 Antibody Key Players Head office and Products Offered
Table 16. HER2 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global HER2 Antibody Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global HER2 Antibody Market Size Market Share by Regions (2019-2024)
Table 21. Global HER2 Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global HER2 Antibody Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas HER2 Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas HER2 Antibody Market Size Market Share by Country (2019-2024)
Table 25. Americas HER2 Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas HER2 Antibody Market Size Market Share by Type (2019-2024)
Table 27. Americas HER2 Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas HER2 Antibody Market Size Market Share by Application (2019-2024)
Table 29. APAC HER2 Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC HER2 Antibody Market Size Market Share by Region (2019-2024)
Table 31. APAC HER2 Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC HER2 Antibody Market Size Market Share by Type (2019-2024)
Table 33. APAC HER2 Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC HER2 Antibody Market Size Market Share by Application (2019-2024)
Table 35. Europe HER2 Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe HER2 Antibody Market Size Market Share by Country (2019-2024)
Table 37. Europe HER2 Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe HER2 Antibody Market Size Market Share by Type (2019-2024)
Table 39. Europe HER2 Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe HER2 Antibody Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa HER2 Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa HER2 Antibody Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa HER2 Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa HER2 Antibody Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa HER2 Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa HER2 Antibody Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of HER2 Antibody
Table 48. Key Market Challenges & Risks of HER2 Antibody
Table 49. Key Industry Trends of HER2 Antibody
Table 50. Global HER2 Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global HER2 Antibody Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global HER2 Antibody Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global HER2 Antibody Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Genentech Inc Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 55. Genentech Inc HER2 Antibody Product Offered
Table 56. Genentech Inc HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Genentech Inc Main Business
Table 58. Genentech Inc Latest Developments
Table 59. Novartis AG Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 60. Novartis AG HER2 Antibody Product Offered
Table 61. Novartis AG Main Business
Table 62. Novartis AG HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Novartis AG Latest Developments
Table 64. Pfizer Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 65. Pfizer HER2 Antibody Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Pfizer Latest Developments
Table 69. Abnova Corporation Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 70. Abnova Corporation HER2 Antibody Product Offered
Table 71. Abnova Corporation Main Business
Table 72. Abnova Corporation HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Abnova Corporation Latest Developments
Table 74. InvivoGen Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 75. InvivoGen HER2 Antibody Product Offered
Table 76. InvivoGen Main Business
Table 77. InvivoGen HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. InvivoGen Latest Developments
Table 79. Celltrion Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 80. Celltrion HER2 Antibody Product Offered
Table 81. Celltrion Main Business
Table 82. Celltrion HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Celltrion Latest Developments
Table 84. Biocon Limited Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 85. Biocon Limited HER2 Antibody Product Offered
Table 86. Biocon Limited Main Business
Table 87. Biocon Limited HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Biocon Limited Latest Developments
Table 89. Bio-Techne Details, Company Type, HER2 Antibody Area Served and Its Competitors
Table 90. Bio-Techne HER2 Antibody Product Offered
Table 91. Bio-Techne Main Business
Table 92. Bio-Techne HER2 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Bio-Techne Latest Developments

List Of Figures

LIST OF FIGURES
.
Figure 1. HER2 Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER2 Antibody Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. HER2 Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. HER2 Antibody Sales Market Share by Country/Region (2023)
Figure 8. HER2 Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global HER2 Antibody Market Size Market Share by Type in 2023
Figure 10. HER2 Antibody in Hospital
Figure 11. Global HER2 Antibody Market: Hospital (2019-2024) & ($ Millions)
Figure 12. HER2 Antibody in Medical Center
Figure 13. Global HER2 Antibody Market: Medical Center (2019-2024) & ($ Millions)
Figure 14. Global HER2 Antibody Market Size Market Share by Application in 2023
Figure 15. Global HER2 Antibody Revenue Market Share by Player in 2023
Figure 16. Global HER2 Antibody Market Size Market Share by Regions (2019-2024)
Figure 17. Americas HER2 Antibody Market Size 2019-2024 ($ Millions)
Figure 18. APAC HER2 Antibody Market Size 2019-2024 ($ Millions)
Figure 19. Europe HER2 Antibody Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa HER2 Antibody Market Size 2019-2024 ($ Millions)
Figure 21. Americas HER2 Antibody Value Market Share by Country in 2023
Figure 22. United States HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC HER2 Antibody Market Size Market Share by Region in 2023
Figure 27. APAC HER2 Antibody Market Size Market Share by Type in 2023
Figure 28. APAC HER2 Antibody Market Size Market Share by Application in 2023
Figure 29. China HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 33. India HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe HER2 Antibody Market Size Market Share by Country in 2023
Figure 36. Europe HER2 Antibody Market Size Market Share by Type (2019-2024)
Figure 37. Europe HER2 Antibody Market Size Market Share by Application (2019-2024)
Figure 38. Germany HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 39. France HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa HER2 Antibody Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa HER2 Antibody Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa HER2 Antibody Market Size Market Share by Application (2019-2024)
Figure 46. Egypt HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country HER2 Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 52. APAC HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 53. Europe HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 55. United States HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 56. Canada HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 57. Mexico HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 58. Brazil HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 59. China HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 60. Japan HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 61. Korea HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 63. India HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 64. Australia HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 65. Germany HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 66. France HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 67. UK HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 68. Italy HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 69. Russia HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 70. Spain HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 71. Egypt HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 72. South Africa HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 73. Israel HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 74. Turkey HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries HER2 Antibody Market Size 2025-2030 ($ Millions)
Figure 76. Global HER2 Antibody Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global HER2 Antibody Market Size Market Share Forecast by Application (2025-2030)